This document discusses cerebral blood flow, intracranial pressure, and their regulation. It describes how blood flows to and drains from the brain through various arteries and veins. Factors like carbon dioxide levels, oxygen levels, metabolism and autoregulation help control cerebral blood flow. Intracranial pressure is maintained by a balance of brain tissue, blood and cerebrospinal fluid, and can increase due to masses, swelling or fluid accumulation. Signs of elevated intracranial pressure include headache, vomiting and altered consciousness. Treatments aim to reduce pressure through drainage, medication and other interventions to preserve adequate cerebral perfusion.
2. Cerebral blood supply
Anterior cerebral circulation and posterior cerebral
circulation
Internal carotid arteries and vertebral arteries
The anterior and posterior cerebral circulations are
interconnected via bilateral posterior communicating
arteries
Part of the Circle of Willis
Provides backup circulation to the brain
8. Cerebral venous drainage
Dural venous sinuses - located on the
surface of the cerebrum.
The most prominent of these sinuses is
the superior sagittal sinus
confluence of sinuses sigmoid
sinuses which go on to form the two
jugular veins
In the neck, jugular veins superior
vena cava.
Deep venous drainage veins inside
the deep structures of the brain, which
join behind the midbrain to form the
vein of Galen merges with the
inferior sagittal sinus to form the
straight sinus which then joins the
superficial venous system mentioned
above at the confluence of sinuses
11. Cerebral blood flow
• Weighs 1400g or 2% of the total body weight
• CBF = 50ml/100g/min
• CBF is 700ml/min or 15% of the resting cardiac output
• High oxygen consumption - 3.3ml/100g/min (50ml/min in
total)
• 20% of the total body consumption --> cerebral metabolic
rate for oxygen or CMRO2
• Higher in the cortical grey matter and generally parallels
cortical electrical activity
13. Cerebral blood flow
1. Affecting cerebral perfusion pressure
2. Affecting the radius of cerebral blood vessels
14. Cerebral Perfusion Pressure
Pressure gradient between the arteries and the veins
Difference between the mean arterial blood pressure
(MAP) and the mean cerebral venous pressure
CPP = MAP – ICP
MAP - diastolic blood pressure + 1/3 pulse pressure
Usually around 90mmHg
ICP is much lower and is normally less than
13mmHg
CPP is normally about 80mmHg
16. Cerebral metabolism
Increases in metabolic
demand met rapidly by
an increase in CBF and
substrate delivery and
viceversa flow-
metabolism coupling
Hydrogen ions,
potassium, CO2,
adenosine, glycolytic
intermediates,
phospholipid metabolites,
nitric oxide
17. pCo2 & CBF
Increase Cerebral Blood Flow in Response to Excess
Carbon Dioxide or Excess Hydrogen Ion Concentration.
CO2 H2O HCO3
H+
IONS
Vasodilatation
Regulated by a complex and interrelated
system of mediators
Nitric oxide, prostanoids, cyclic
nucleotides, potassium
channels, Calcium
18. pCo2 & CBF
Moderate hypotension -- impairs the response of the cerebral
circulation to changes in PaCO2
The response of the cerebral vessels to CO2 can be utilised to help
manage patients with raised intracranial pressure, for example after
traumatic brain injury
Hyperventilation reduces the PaCO2 vasoconstriction
reduces cerebral blood volume and ICP
However if PaCO2 is reduced too much vasoconstriction
worsening cerebral ischaemia
Hypercapnia and the resulting vasodilatation and increase in ICP
must be avoided
PaCO2 - best maintained at low-normal levels to prevent raising ICP
This reactivity may be lost in areas of the brain that are injured
CO2 reactivity is generally preserved during inhalation anaesthesia
and can therefore be utilised to help control ICP and brain swelling
during surgery
19. Oxygen & CBF
CBF increases once
PaO2 drops below
50mmHg so that cerebral
oxygen delivery remains
constant
Release of
adenosine/prostanoids
cerebral vasodilatation
Cerebrovascular smooth
muscle
hyperpolarisation and
reduce calcium uptake
both mechanisms
enhancing vasodilatation
21. Myogenic (autoregulation)
Cerebral autoregulation – ability to maintain a relatively
constant organ bld flow over a range of perfusion
pressure
Autoregulation MAP 70 to 150 mmHg
Below / above 70 -150 CBF becomes pressure
passive
22. Mechanism
Myogenic
Intrinsic response of myogenic
smooth muscle in cerebral
arterioles to changes in MAP
(NO)
Autonomic innervation of cerebral
blood vessels May also contribute
to autoregulation of blood flow
Metabolic
CMR determines arteriolar tone
when tissue demand exceeds
blood flow
release of tissue metabolites
Vasodilatation
CBF
23. Chronic hypertension - shifts Autoregulation curve to
right
Protects the brain against “ breakthrough” by surpassing
the upper limit of autoregulation, at expense of lower limit
Symptoms of cerebral hypoxia do not occur even at MAP
35-40 mmHg in normotensives but can appear at a
significantly higher BP in chronic hypertensives
Vascular hypertrophy size of intravascular lumen
proximal conductance vessel resistance
Autoregulation
25. Vascular changes & autoregulatory shift induced by
chronic HTN is modified by long term anti-HTN therapy,
degree of reversal determined by length of t/t
Head trauma, brain lactic acidosis, brain injury – abolish
autoregulation
Tumour brain tissue blood flow is not autoregulated
Potent inhaled anaesthetics & hypercarbia abolish
autoregulation in a dose dependent manner
Autoregulation
26. Temperature
CMR decreases by 6 to 7 % / degree temp reduction
Hyperthermia
37 to 42° C CBF & CMR increase
>42°C dramatic reduction in cerebral
O2consumption (toxic effect of protein enzyme
degradation )
27. Viscosity
Blood vicosity can influence CBF.
In healthy subjects variation in hematocrit 33 – 45%
caused only modest alteration in CBF
Anemia CVR CBF ( viscosity & O2 carrying
capacity)
Aging from childhood to adulthood progressive
reduction in CBF & CMRO2
Age
29. Intracranial pressure
Intracranial pressure (ICP) is the pressure inside the skull
Skull has three essential components:
- Brain tissue = 78%
- Blood = 12%
- Cerebrospinal fluid (CSF) = 10%
Any increase in any of these tissues causes increased
ICP
30. Intracranial pressure
Normal value - 7–15 mmHg
Factors that influence ICP
Arterial pressure
Venous pressure
Intraabdominal and intrathoracic pressure
Posture
Temperature
Blood gases (CO2 levels)
31. Intracranial pressure
Normal compensatory adaptations
Alteration of CSF absorption or production
Displacement of CSF into spinal subarachnoid space
Dispensability of the dura
32. Causes of raised ICP
Mass effect - Brain tumor, infarction with edema, subdural or
epidural hematoma
Generalized brain swelling can occur in ischemic-anoxia
states, acute liver failure, hypertensive encephalopathy, hypercarbia,
and Reye hepatocerebral syndrome
Increase in venous pressure - venous sinus thrombosis, heart
failure, obstruction of jugular veins.
Obstruction to CSF flow / absorption - hydrocephalus , extensive
meningeal disease (e.g., infection, carcinoma, granuloma,
or hemorrhage), or obstruction in cerebral convexities and superior
sagittal sinus (decreased absorption).
Increased CSF production - meningitis, subarachnoid hemorrhage,
or choroid plexus tumor.
Idiopathic intracranial hypertension
Craniosynostosis
33. Pathophysiology
Increase in any of its contents—brain, blood, or CSF—
will tend to increase the ICP
Small increases in brain volume do not lead to immediate
increase in ICP
Because - ability of the CSF to be displaced into the
spinal canal & ability to stretch the falx cerebri between
the hemispheres and the tentorium between the
hemispheres and the cerebellum
34. Pathophysiology
Injury to the brain occurs both at the time of the initial
trauma (the primary injury) and subsequently due to
ongoing cerebral ischemia (secondary injury).
Cerebral perfusion pressure = CBF – ICP
Once the ICP approaches the level of the mean systemic
pressure, cerebral perfusion falls
Body’s response to a fall in CPP raise systemic blood
pressure and dilate cerebral blood vessels
Results in increased cerebral blood volume, which
increases ICP, lowering CPP further and causing vicious
cycle
35. Pathophysiology
Severely raised ICP, if caused by a unilateral space-
occupying lesion can result in midline shift
Midline shift can compress the ventricles and lead to
hydrocephalus
Prognosis is much worse in patients with midline shift
Increased ICP combined with a space-occupying process
is brain herniation
36. Signs and symptoms of raised ICP
Headache, vomiting without nausea, ocular palsies, altered
level of consciousness, back pain and papilledema
If papilledema is protracted visual disturbances, optic
atrophy, and blindness
Headache - classically a morning headache
Worse on coughing / sneezing / bending, and progressively
worsens over time
If mass effect is present - pupillary dilatation, abducens
palsies, and Cushing's triad
Cushing's triad involves an increased systolic blood pressure,
a widened pulse pressure, bradycardia, and Cheyne–Stokes
respiration
37. Signs and symptoms of raised ICP
Patients with normal blood pressure retain normal
alertness with ICP of 25–40 mmHg
Only when ICP exceeds 40–50 mmHg, CPP and
cerebral perfusion decrease to a level that results in
loss of consciousness
Any further elevations will lead to brain infarction and
brain death
38. Investigations
CT brain – Haemorrhage, Hydrocephalus, space
occupying lesions, midline shift
MRI brain – Acute ischemic stroke, central venous sinus
thrombosis
EEG – Seizures, recurrent status epileptics, severe brain
dysfunction
LP – Infection , to look for the opening pressure
ICP monitoring
40. Treatment for raised ICP
Insert ICP monitoring – ventriculostomy or
parenchymal device
General goals – to maintain ICP < 20mmHg and
CPP > 60 mmHg
IF ICP > 20 – 25 mmHg for > 5 min
Drain CSF via ventriculosotmy
41. Treatment for raised ICP
Sedation – morphine / propofol / midazolam
Neuromuscular paralysis if required
Hyperventilation - PaCo2 of 30 – 35 mmHg
42. Treatment for raised ICP
Elevate head end of bed – 30degree
Osmotherapy – Mannitol 25 – 100 g Q4H (Maintain
serum osmolality < 320mosmol) or hypertonic saline
( 30ml, 23.4% Nacl bolus)
Glucocorticoids – Dexamethasone 4mg Q6H for
vasogenic oedema from tumour
43. Treatment for raised ICP
Pressor therapy – Phenylephrine, dopamine or
norepinephrine to maintain adequate MAP to ensure
CPP > 60 mmHg
Consider second line therapies for refractory
elevated ICP
High dose barbiturate
Aggressive hyperventilation to PaCo2 < 30mmHg
Hypothermia
Hemicraniectomy
In case one of the supply arteries is occluded, the Circle of Willis provides interconnections between the anterior and the posterior cerebral circulation along the floor of the cerebral vault, providing blood to tissues that would otherwise become ischemic.